NOV 19, 2017 2:02 PM PST

Expectation vs. Reality for Cancer Patients in Trials

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Cancer patients participating in clinical trials may have their expectations set too high, say researchers. In particular, patients were keen to see their tumor shrink and some even expected a complete cure. While these scenarios would be ideal for everyone involved, the reality often proves to be more challenging.

Clinical trials are the gold standard by which all drugs, devices, or treatments must meet before being marketed to the public. Through several rigorous phases, a treatment must be proven safe and efficacious in human participants.
 
For any treatment to get to clinical trial is already a big deal – it means that the treatment has passed through the burden of research and development in the lab and in animal trials. This process alone can take as long as decades. So when a treatment is ready to be tested in people, it means there’s much evidence to hope that the treatment will work in people too.
 
Indeed, cancer patients appear to be counting on the research to pay off for them, understandably. In a study with 396 cancer patients who were considering to enter a Phase I clinical trial, researchers found that a large percentage expected positive results from the treatment. Specifically, nearly 43 percent predicted the tumor would shrink even before consulting with clinicians. And after consultation, patients’ hopes only increased, as 47 percent predicted tumor shrinkage.
 
Of note, the clinical trial available to the participants was a Phase I trial, which is designed to screen for safety. Essentially, this important step determines whether a treatment is safe in people, and at what dose do the side effects occur. Typically, this phase of the study is restricted to a small number of patients for whom standard therapy has not worked. Response rate is usually between 4 and 20 percent, while the median survival time for the enrolled participants is 6 months.
 
Nevertheless, it must be said that positive expectations can be great weapons against cancer.


"There is a positive message in this, which is that 84 percent of patients are willing to participate in phase I oncology studies after a discussion with clinical and nursing staff who lay out the conservative estimates of benefit and requirements of hospital visits. This is good for current and future patients and cancer medicine in general," said Udai Banerji from the NHS Foundation Trust and The Institute of Cancer Research, who led the study.
 
"The high percentage of patients expecting their tumors to shrink was a sobering finding. This creates a challenge for healthcare professionals to manage expectations but to do so without being patronizing or dismissing human hope," Banerji added. It’s a fine balance between encouraging patients to fight their disease and also offering them the appropriate information to guide their decisions, and perhaps these results underscore the need to improve for both doctors and patients.

Additional sources: Wiley press release via MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 17, 2021
Cancer
Analyzing the role of our circadian clocks in prostate cancer
JAN 17, 2021
Analyzing the role of our circadian clocks in prostate cancer
Research published recently in Nature Communications looks into the role that circadian rhythms play on prostate cancer ...
FEB 17, 2021
Clinical & Molecular DX
Urine Test Bypasses the Need for Prostate Biopsies
FEB 17, 2021
Urine Test Bypasses the Need for Prostate Biopsies
Researchers have created a urine test for prostate cancer that could make unnecessary biopsies a thing of the past. The ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 19, 2021
Cancer
What does RNA editing do to the immune system?
MAR 19, 2021
What does RNA editing do to the immune system?
A recent study published in the journal Nature Communications from the University of Colorado Cancer Center explores new ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 05, 2021
Cannabis Sciences
Can Smoking Cannabis Cause Lung Cancer?
APR 05, 2021
Can Smoking Cannabis Cause Lung Cancer?
So far, there is no firm consensus on whether smoking cannabis can cause lung cancer. As cannabis smoke contains many si ...
Loading Comments...